Assessing the Relationship between Disordered Gamblers with Psychosis and Increased Gambling Severity: The Mediating Role of Impulsivity

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS INC
Autores
KIM, Hyoun S.
CASSETTA, Briana D.
HODGINS, David C.
TOMFOHR-MADSEN, Lianne M.
MCGRATH, Daniel S.
Citação
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, v.63, n.6, p.370-377, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: Recent research suggests that disordered gambling and psychosis co-occur at higher rates than expected in the general population. Gamblers with psychosis also report greater psychological distress and increased gambling severity. However, the mechanism by which psychosis leads to greater gambling symptomology remains unknown. The objective of the present research was to test whether impulsivity mediated the relationship between comorbid psychosis and gambling severity. Method: The sample consisted of 394 disordered gamblers voluntarily seeking treatment at a large university hospital in SAo Paulo, Brazil. A semistructured clinical interview (Mini-International Neuropsychiatric Interview) was used to diagnosis the presence of psychosis by registered psychiatrists. Severity of gambling symptoms was assessed using the Gambling Symptom Assessment Scale, and the Barratt Impulsiveness Scale-11 provided a measure of impulsivity. Results: Of the sample, 7.2% met diagnostic criteria for psychosis. Individuals with a dual diagnosis of psychosis did not report greater gambling severity. Conversely, dual diagnoses of psychosis were associated with greater levels of impulsivity. Higher levels of impulsivity were also associated with greater gambling severity. Importantly, support for our hypothesised mediation model was found such that impulsivity mediated the association between disordered gambling and psychosis and gambling severity. Conclusion: Impulsivity appears to be a transdiagnostic process that may be targeted in treatment among disordered gamblers with a dual diagnosis of psychosis to reduce problematic gambling behaviours.
Palavras-chave
psychosis, disordered gambling, impulsivity, mediation
Referências
  1. Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565
  2. American Psychiatric Association, 2013, DIAGN STAT MAN MENT
  3. Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106
  4. Andrade L, 2002, SOC PSYCH PSYCH EPID, V37, P316, DOI 10.1007/s00127-002-0551-x
  5. Aragay N, 2012, COMPR PSYCHIAT, V53, P9, DOI 10.1016/j.comppsych.2011.02.004
  6. BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
  7. Bickel WK, 2011, BIOL PSYCHIAT, V69, P260, DOI 10.1016/j.biopsych.2010.08.017
  8. Blaszczynski A, 2002, ADDICTION, V97, P487, DOI 10.1046/j.1360-0443.2002.00015.x
  9. Brevers D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050647
  10. Cassetta B, SCHIZOPHR RES
  11. Craske MG, 2012, DEPRESS ANXIETY, V29, P749, DOI 10.1002/da.21992
  12. Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591
  13. Cunningham-Williams RM, 1998, AM J PUBLIC HEALTH, V88, P1093, DOI 10.2105/AJPH.88.7.1093
  14. Desai RA, 2009, J CLIN PSYCHIAT, V70, P1250, DOI [10.4088/JCP.08m04359, 10.4088/JCP.m04359]
  15. Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449
  16. Enticott PG, 2008, PSYCHIAT RES, V157, P251, DOI 10.1016/j.psychres.2007.04.007
  17. GOLDSTEIN JM, 1988, J PSYCHIAT RES, V22, P141, DOI 10.1016/0022-3956(88)90078-7
  18. Griffiths M, 2004, BRIT MED J, V329, P1055, DOI 10.1136/bmj.329.7474.1055
  19. Gut-Fayand A, 2001, PSYCHIAT RES, V102, P65, DOI 10.1016/S0165-1781(01)00250-5
  20. Haydock M, 2015, COMPR PSYCHIAT, V58, P122, DOI 10.1016/j.comppsych.2015.01.003
  21. Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360
  22. Hodgins DC, 2015, INT J MENT HEALTH AD, V13, P699, DOI 10.1007/s11469-015-9572-z
  23. Hodgins DC, 2011, LANCET, V378, P1874, DOI 10.1016/S0140-6736(10)62185-X
  24. Houben K, 2011, PSYCHOL SCI, V22, P968, DOI 10.1177/0956797611412392
  25. Johnson SL, 2013, J AFFECT DISORDERS, V150, P872, DOI 10.1016/j.jad.2013.05.004
  26. Kester HM, 2006, SCHIZOPHR RES, V85, P113, DOI 10.1016/j.schres.2006.02.028
  27. Kim SW, 2009, PSYCHIAT RES, V166, P76, DOI 10.1016/j.psychres.2007.11.008
  28. Kim SW, 2001, INT CLIN PSYCHOPHARM, V16, P285, DOI 10.1097/00004850-200109000-00006
  29. Kotov R, J ABNORM PSYCH
  30. Kraplin A, 2014, ADDICT BEHAV, V39, P1646, DOI 10.1016/j.addbeh.2014.05.021
  31. Krueger RF, 2015, WORLD PSYCHIATRY, V14, P27, DOI 10.1002/wps.20175
  32. Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8
  33. Lee TY, 2013, PROG NEURO-PSYCHOPH, V45, P165, DOI 10.1016/j.pnpbp.2013.04.008
  34. Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3
  35. Lister JJ, 2015, CAN J PSYCHIAT, V60, P369, DOI 10.1177/070674371506000806
  36. Lorains FK, 2011, ADDICTION, V106, P490, DOI 10.1111/j.1360-0443.2010.03300.x
  37. MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0
  38. MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542
  39. Meltzer HY, 2012, CURR PHARM BIOTECHNO, V13, P1572
  40. Merkouris SS, 2016, CLIN PSYCHOL REV, V48, P7, DOI 10.1016/j.cpr.2016.06.004
  41. Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783
  42. Nolen-Hoeksema S, 2011, PERSPECT PSYCHOL SCI, V6, P589, DOI 10.1177/1745691611419672
  43. Nower L, 2017, PSYCHOL ADDICT BEHAV, V31, P95, DOI 10.1037/adb0000234
  44. Ouzir M, 2013, AGGRESS VIOLENT BEH, V18, P247, DOI 10.1016/j.avb.2012.11.014
  45. Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
  46. Peraala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19
  47. Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482
  48. Potenza MN, 2001, AM J PSYCHIAT, V158, P1500, DOI 10.1176/appi.ajp.158.9.1500
  49. Potenza MN, 2001, AM J PSYCHIAT, V158, P497, DOI 10.1176/appi.ajp.158.3.497-a
  50. Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
  51. Ramos-Grille I, 2015, ADDICT BEHAV, V43, P54, DOI 10.1016/j.addbeh.2014.12.010
  52. Ramos-Grille I, 2013, PSYCHOL ASSESSMENT, V25, P599, DOI 10.1037/a0031930
  53. Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009
  54. Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X
  55. Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008
  56. Tavares H, 2007, REV BRAS PSIQUIATR, V29, P107, DOI 10.1590/S1516-44462007000200005
  57. Wu AD, 2008, SOC INDIC RES, V87, P367, DOI 10.1007/s11205-007-9143-1
  58. Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855
  59. Yakovenko I, 2016, SCHIZOPHR RES, V171, P50, DOI 10.1016/j.schres.2015.12.008